The Impact of Inflammatory Bowel Disease Severity and Medication on Subsequent Specific Hematologic Neoplasm

The Impact of Inflammatory Bowel Disease Severity and Medication on Subsequent Specific Hematologic Neoplasm

碩士 === 國立成功大學 === 臨床醫學研究所碩士在職專班 === 104

Bibliographic Details
Main Authors:	Chien-LiangLin, 林建良
Other Authors:	Sheng-Hsiang Lin
Format:	Others
Language:	en_US
Published:	2016
Online Access:	http://ndltd.ncl.edu.tw/handle/90649406312162047363

Similar Items

Autoimmune Complications in Hematologic Neoplasms
by: Wilma Barcellini, et al.
Published: (2021-03-01)

Specific Features of Vascular Endothelium in Patients with Severe Forms of Inflammatory Bowel Diseases
by: O. V. Khlynova, et al.
Published: (2018-11-01)

Biomarkers and Hematological Indices in the Diagnosis of Iron Deficiency in Children with Inflammatory Bowel Disease
by: Paulina Krawiec, et al.
Published: (2020-05-01)

Immunotherapy in Pediatric Hematologic Malignant Neoplasms
by: Kyung Taek Hong
Published: (2020-04-01)

Viral etiology in pediatric hematological neoplasms
by: Abigail Morales-Sánchez, et al.
Published: (2016-01-01)

Subsequent Malignant Neoplasms in Retinoblastoma Survivors
by: Armida W. M. Fabius, et al.
Published: (2021-03-01)

Inflammatory bowel disease: Medical management
by: Al-Gindan Yusuf
Published: (1995-01-01)

Medication adherence in inflammatory bowel disease
by: Webber Chan, et al.
Published: (2017-10-01)

Overview of Subsequent Entry Biologics for the Management of Inflammatory Bowel Disease and Canadian Association of Gastroenterology Position Statement on Subsequent Entry Biologics
by: Shane M Devlin, et al.
Published: (2013-01-01)

The Clinical Characteristics of ARDS in Children With Hematological Neoplasms
by: Qiao Zhang, et al.
Published: (2021-07-01)

The role of JAK2 abnormalities in hematologic neoplasms.
by: Mohammed Khalid Alabdulaali
Published: (2009-07-01)

Bone mineral density and inflammatory bowel disease severity
by: C.A. Lima, et al.
Published: (2017-10-01)

Risk of Inflammatory Bowel Disease in Patients with Chronic Myeloproliferative Neoplasms: A Danish Nationwide Cohort Study
by: Marie Bak, et al.
Published: (2020-09-01)

The association between cholecystectomy and colorectal neoplasm in inflammatory bowel diseases: A population-based cohort study.
by: Yen-Chun Peng, et al.
Published: (2017-01-01)

Susceptibility of Ti-6Al-4V Alloy to Stress Corrosion Cracking in Aluminum Chloride-1-ethyl-3-methylimidazolium Chloride Ionic Liquids
by: Chien-LiangLin, et al.
Published: (2013)

Applying Decision Trees to Find The Potential Customers for Inventory – A Case Study on a Steel Company
by: Chien-LiangLin, et al.
Published: (2015)

Advances in Imaging Specific Mediators of Inflammatory Bowel Disease
by: Nicole Dmochowska, et al.
Published: (2018-08-01)

Educational Case: Systemic Mastocytosis with an Associated Hematological Neoplasm
by: Brenda Mai MD, et al.
Published: (2020-02-01)

Does the Level of Reproductive Knowledge Specific to Inflammatory Bowel Disease Predict Childlessness among Women with Inflammatory Bowel Disease?
by: Vivian W Huang, et al.
Published: (2015-01-01)

Complementary and alternative medications in the management of inflammatory bowel disease
by: Sherman Picardo, et al.
Published: (2020-05-01)

Patient Non-Adherence to Medication in Inflammatory Bowel Disease
by: Alan BR Thomson
Published: (2004-01-01)

Disease-Specific Enteric Microbiome Dysbiosis in Inflammatory Bowel Disease
by: Hengameh Chloé Mirsepasi-Lauridsen, et al.
Published: (2018-11-01)

An Overview of Tools to Score Severity in Pediatric Inflammatory Bowel Disease
by: Ron Shaoul, et al.
Published: (2021-04-01)

Unravelling the impact of MGAT5 non-coding genetic variants in Inflammatory Bowel Disease severity
by: Nuno André Dias Padrão
Published: (2019)

Small-Bowel Neoplasms: Role of MRI Enteroclysis
by: Angela Faggian, et al.
Published: (2016-01-01)

The Economic Impact of Inflammatory Bowel Disease in Canada
by: Robert Hilsden
Published: (2004-01-01)

Economic Impact of Inflammatory Bowel Disease in Alberta
by: B.R. Pinchbeck, et al.
Published: (1988-01-01)

Current roles of specific bacteria in the pathogenesis of inflammatory bowel disease
by: Lucy McMullen, et al.
Published: (2015-12-01)

Update on the management of inflammatory bowel disease: specific role of adalimumab
by: Guidi L, et al.
Published: (2011-07-01)

Quality of life and functional capacity during the treatment of hematologic neoplasms
by: Monique Vanderlinde de Souza, et al.
Published: (2018-10-01)

Rare hematologic neoplasms an acute megakaryocytic leukemia case report
by: Sorina Mihaela Chiriac, et al.
Published: (2010-06-01)

Concomitant detection of hematological neoplasm and carcinoma: report on seven cases
by: Mariana Montenegro de Melo Lira, et al.

Epigenetic Effects of Benzene in Hematologic Neoplasms: The Altered Gene Expression
by: Giovanna Spatari, et al.
Published: (2021-05-01)

The Bowel Microbiota and Inflammatory Bowel Diseases
by: Gerald W. Tannock
Published: (2010-01-01)

Inflammatory Microenvironment and Specific T Cells in Myeloproliferative Neoplasms: Immunopathogenesis and Novel Immunotherapies
by: Vincenzo Nasillo, et al.
Published: (2021-02-01)

The Factors Associated with Severe Cutaneous Adverse Drug Reactions and the Subsequent Medical Consumptions
by: MAO CHIEN TAI, et al.
Published: (2007)

Medical and surgical treatment of inflammatory bowel disease in the province of Albacete
by: Gonzalo Fidel Martínez Jiménez, et al.
Published: (2016-09-01)

Medication non-adherence in inflammatory bowel diseases is associated with disability
by: Jonathan Perry, et al.
Published: (2018-10-01)

Medical Management of Inflammatory Bowel Disease among Canadian Gastroenterologists
by: J Jones, et al.
Published: (2011-01-01)

Inflammatory Bowel Disease: Appreciating Disability and Impact of Disease
by: Subrata Ghosh
Published: (2015-01-01)

Cannot write session to /tmp/vufind_sessions/sess_02vc0jqgqdcba6n0i62hpjqnda